Invivoscribe PCR/CE tests for lymphoproliferative diseases
Standardized tools for detection and monitoring of lymphoproliferative diseases
Invivoscribe exclusively offers a comprehensive selection of PCR-based assays for ABI fluorescence detection, including targeted FLT3 mutation assays, B- and T-cell clonality assays (based on EuroClonality/BIOMED-2 Concerted Action BMH4-CT98-3936), and translocation assays. LeukoStrat CDx FLT3 is the first IVDR certified kit for AML diagnosis.
Leukemias and lymphomas originate from the malignant transformation of individual lymphoid cells, all leukemias and lymphomas generally share one or more cell-specific or “clonal” antigen receptor gene rearrangements. Therefore, tests that detect clonal rearrangements can be useful in the study of B- and T-cell malignancies.
Product is available in the following countries: